ReviewFrontiers in immunology2026
A shared stress-inflammation signalling architecture underlying chronic disease and multimorbidity.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Systemic Neutralization of Granulocyte-Macrophage Colony-Stimulating Factor Attenuates Stellate Ganglion Neuroinflammation and Cardiac Sympathetic Overactivation in Chronic Heart Failure in Rats.International journal of molecular sciences · 2026Article
- The integrated theory of carcinogenesis: cancer as dysregulated persistence under chronic systemic stress.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic non-communicable diseases are conventionally classified as distinct clinical entities, yet multimorbidity has become the dominant phenotype in modern populations. Converging experimental, clinical and epidemiological evidence indicates that metabolic overload-characterised by persistent hyperinsulinaemia, insulin resistance and nutrient-driven anabolic signalling-acts as a central amplifier of conserved stress-response systems and chronic low-grade inflammatory signalling. Under contemporary exposome conditions, sustained metabolic stress chronically engages sympathetic and renin-angiotensin-aldosterone signalling, oxidative stress pathways and innate immune activation, establishing a tightly coupled feed-forward network that stabilises pathological states across organ systems. Here, I synthesise mechanistic data from endocrinology, immunometabolism, vascular biology and ageing research to propose a unified stress-signalling architecture linking systemic stress axes to shared intracellular integration hubs. These include inflammatory transcriptional regulators (NF-κB, AP-1), stress-activated kinases (MAPKs), and nutrient- and oxygen-sensing pathways centred on PI3K-Akt-mTOR and HIF-1α, with additional modulation by Notch signalling. When cytoprotective buffering and stress-resolution mechanisms-particularly NRF2 activity, autophagy and mitochondrial resilience-are insufficient, persistent activation of these hubs enforces inflammatory tone, metabolic inflexibility, impaired proteostasis and maladaptive tissue remodelling, providing a mechanistic explanation for phenotypic convergence across cardiometabolic, inflammatory, degenerative and hyperplastic diseases. Importantly, epidemiological and anthropological observations indicate that multimorbidity is not an inevitable consequence of ageing per se, but instead reflects environmentally contingent persistence of stress-response programmes rather than intrinsic ageing trajectories. Framing chronic disease through this integrated metabolic-stress signalling architecture positions multimorbidity as a mismatch phenotype rather than a programmed endpoint of human longevity, and highlights upstream stress regulation and restoration of metabolic resilience as central targets for system-level prevention and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.